← Leaderboards
Daniel Chang Cho
Beth Israel Deaconess Medical Center
$847,000
Attributed
$847,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $169.4K · FY2009–13$200K$150K$100K$50K$0
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$847,000 · 1
By mechanism
K08$847,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Michael B Atkins$4,622,469
- David McDermott$9,360,637
- Barbara B Kahn$32,891,170
- Cornelis P Terhorst$22,963,281
- Lewis C Cantley$35,988,650
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Martin Friedlander · Scripps Research Institute$48,350,175
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
Research focus
AngiogenesisAngiogenesis InhibitorsApoptosisApoptoticBaseBay 54-9085Cancer TherapyCareerCell GrowthCell LineCell SurvivalClinical EfficacyClinically SignificantCommitConsensusDensityDisease ProgressionDrug Delivery SystemsDrug DevelopmentDrug EfficacyEndothelial CellsEndotheliumFailure (Biologic Function)1-Phosphatidylinositol 3-Kinase
Grant awards (5)
Targeting the PI3-Kinase/Akt Pathway for the Therapy of Renal Cell Carcinoma$169,400
K08 · FY2013 · CA · contact PI
Targeting the PI3-Kinase/Akt Pathway for the Therapy of Renal Cell Carcinoma$169,400
K08 · FY2012 · CA · contact PI
Targeting the PI3-Kinase/Akt Pathway for the Therapy of Renal Cell Carcinoma$169,400
K08 · FY2011 · CA · contact PI
Targeting the PI3-Kinase/Akt Pathway for the Therapy of Renal Cell Carcinoma$169,400
K08 · FY2010 · CA · contact PI
Targeting the PI3-Kinase/Akt Pathway for the Therapy of Renal Cell Carcinoma$169,400
K08 · FY2009 · CA · contact PI